- Abstract Number: 0288
A Comparative Study of Clinical Manifestations of Yao Syndrome and Systemic Lupus Erythematosus
- Abstract Number: 1735
A Comparison of Healthcare Resource Utilization Amongst African American Women with and without Systemic Lupus Erythematosus (SLE)
- Abstract Number: 0471
A Comprehensive Risk Score Integrating Genetic, Environmental, and Clinical Factors to Assess Incident Rheumatoid Arthritis Risk
- Abstract Number: 1869
A Computer Vision Approach for the Detection of Joint Effusions Using Digital Hand Photographs
- Abstract Number: 1478
A Consensus Based Foot and Ankle Examination of the Adult for Rheumatology Training
- Abstract Number: 2842
A Cross-Platform Urinary Proteomic Atlas of Disease Activity, Treatment Response, and Kidney Function Loss in Lupus Nephritis
- Abstract Number: 0669
A Deep Dive Into Safety: 2.5 Year Follow Up of Chikungunya Virus (CHIKV) Virus-Like Particle (VLP) Vaccine
- Abstract Number: 2129
A deep learning model predicting the survival of Anti-neutrophil cytoplasmic antibody -associated vasculitis
- Abstract Number: 1894
A Distinctive Serum Proteomic Signature of Ocular Ischemia in Giant Cell Arteritis Showing Attenuated Circulating Adaptive Immunity and an IL-33/ST2 Innate-Tissue Axis
- Abstract Number: 2066
A Genome-Scale, In Vivo Transcription Factor Screen Identifies a Previously Unrecognized Factor That Enhances CAR-T Persistence and Tumor Control Under High-Dose Rechallenge
- Abstract Number: 1770
A Hard Pill to Swallow: A Lupus Nephritis Medication Adherence Pilot Using Proactive Screening and Clinical Pharmacy Intervention
- Abstract Number: 2042
A Homozygous IRAK2 Q127H Variant Drives Exaggerated Innate and Interferon Signaling in IFN-high Still’s Disease
- Abstract Number: 1035
A Human Joint-on-a-Chip Platform Reveals Anti-inflammatory Effects of Cytokine-Rich Autologous Serum Derived from Patients with Rheumatoid Arthritis
- Abstract Number: 0779
A Large Language Model Framework for Advancing Evidence-Based Rheumatology Care: Integration of Biomedical Literature and Pharmacovigilance Data
- Abstract Number: 1929
A lupus nephritis endotype is driven by gut microbial lipoglycan through TLR2-independent, lectin receptor-mediated immune activation
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.